FDA Inspection 1262847 — Neosoma, Inc.

Neosoma, Inc. — FEI 3024812789

The FDA completed an inspection of Neosoma, Inc. on Feb 21, 2025 in Groton, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 3 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Feb 21, 2025
Fiscal Year
2025
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Groton, MA (United States)

Citations

IDCFRDescription
1471221 CFR 820.184DHR - not or inadequately maintained
328621 CFR 820.90(b)(1)Procedures for product review,disposition lack of/inadequate
333121 CFR 820.181DMR - not or inadequately maintained

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.